Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page
- Check4 days agoChange DetectedUpdated the iRECIST citation to revision v3.4.3, replacing the previous v3.4.2 citation.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA minor version update was applied: from v3.4.1 to v3.4.2, with no substantive content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 in the site's revision tag; this change is cosmetic and does not modify any study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a 'Show glossary' option and updated labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision tag changed from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. This is a metadata update and does not change the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check83 days agoChange DetectedDifference1%

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.